EUVIMEDEUVIMED entdecken
Open Access

Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

Yuanzhang Zhou iD, Peng Chu iD, Ya Wang, Na Li iD, Qiong Gao iD, Shengnan Wang, Juncheng Wei, Guoqing Xue iD, Yue Zhao iD, Huijun Jia iD, Jiankun Song iD, Yue Zhang iD und 13 weitere

Science Advances · 16.08.2024 · 10 (33)

DOI: 10.1126/sciadv.ado1533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 16.08.2024. Verfasst von Yuanzhang Zhou und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Lipolysis, Ubiquitin Thiolesterase, Epinephrine. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic stress–induced epinephrine (EPI) accelerates breast cancer progression and metastasis, but the molecular mechanisms remain unclear. Herein, we found a strong positive correlation between circulating EPI levels and the tumoral expression of ubiquitin-specific peptidase 22 (USP22) in patients with breast cancer. USP22 facilitated EPI-induced breast cancer progression and metastasis by enhancing adipose triglyceride lipase (ATGL)–mediated lipolysis. Targeted USP22 deletion decreased ATGL expression and lipolysis, subsequently inhibiting EPI-mediated breast cancer lung metastasis. USP22 acts as a bona fide deubiquitinase for the Atgl gene transcription factor FOXO1, and EPI architects a lipolysis signaling pathway to stabilize USP22 through AKT-mediated phosphorylation. Notably, USP22 phosphorylation levels are positively associated with EPI and with downstream pathways involving both FOXO1 and ATGL in breast cancers. Pharmacological USP22 inhibition synergized with β-blockers in treating preclinical xenograft breast cancer models. This study reveals a molecular pathway behind EPI’s tumor-promoting effects and provides a strong rationale for combining USP22 inhibition with β-blockers to treat aggressive breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLipolysisUbiquitin ThiolesteraseEpinephrineFemaleHumansAnimalsMiceCell Line, TumorForkhead Box Protein O1LipaseSignal TransductionNeoplasm MetastasisPhosphorylationLung NeoplasmsGene Expression Regulation, NeoplasticAcyltransferases

Substanzen

Ubiquitin ThiolesteraseEpinephrineUsp22 protein, humanForkhead Box Protein O1LipasePNPLA2 protein, humanAcyltransferases

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • Dalian College of Pharmacy, Dalian Medical University, Dalian 116044, China.
  • Department of Breast Surgery, First Affiliated Hospital of Dalian Medical University, Dalian 116044, China.
  • Department of Pathology & Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Department of Clinical Laboratory, Dalian Municipal Central Hospital, Dalian 116000, China.
  • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

ORCID-Profile: Yuanzhang Zhou, Peng Chu, Na Li, Qiong Gao, Guoqing Xue, Yue Zhao, Huijun Jia, Jiankun Song, Yue Zhang, Yujie Pang, Houyu Zhu, Jia Sun, Suxian Ma, Chen Su, Bingjin Hu, Zhuoyue Zhao, Jian Wang, Hongjiang Wang, Zhaolin Sun, Deyu Fang

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Zhou, Y., Chu, P., Wang, Y., Li, N., Gao, Q., Wang, S., Wei, J., Xue, G., Zhao, Y., Jia, H., Song, J., Zhang, Y., Pang, Y., Zhu, H., Sun, J., Ma, S., Su, C., Hu, B., Zhao, Z., …, & Fang, D. (2024). Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit. Science Advances, 10(33). https://doi.org/10.1126/sciadv.ado1533

Vancouver

Zhou Y, Chu P, Wang Y, Li N, Gao Q, Wang S, et al. Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit. Science Advances. 2024;10(33). doi:10.1126/sciadv.ado1533

BibTeX
@article{Zhou2024,
  author = {Zhou, Yuanzhang and Chu, Peng and Wang, Ya and Li, Na and Gao, Qiong and Wang, Shengnan and Wei, Juncheng and Xue, Guoqing and Zhao, Yue and Jia, Huijun and Song, Jiankun and Zhang, Yue and Pang, Yujie and Zhu, Houyu and Sun, Jia and Ma, Suxian and Su, Chen and Hu, Bingjin and Zhao, Zhuoyue and Zhang, Hui and Lu, Janice and Wang, Jian and Wang, Hongjiang and Sun, Zhaolin and Fang, Deyu},
  title = {Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {33},
  doi = {10.1126/sciadv.ado1533}
}
Kostenlos starten →